SS-DRPL:基于语音检测帕金森病的自我监督深度表示模式学习
Tae Hoon Kim1, Moez Krichen2, Stephen Ojo3
1School of Information and Electronic Engineering, Zhejiang University of Science and Technology, Hangzhou, Zhejiang, China.
Frontiers in computational neuroscience
|June 27, 2024
概括
自主监督的深度表示模式学习 (SS-DRPL) 显著改善了基于语音的帕金森病 (PD) 检测. 使用SS-DRPL的LSTM-RNN模型获得了高F1得分,提高了诊断准确度.
科学领域:
- 神经学 神经学
- 计算机科学 计算机科学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 是一个全球性的健康挑战,需要准确的诊断工具.
- 语音分析提供了一种非侵入性方法来检测PD.
- 自主监督的深度表示模式学习 (SS-DRPL) 显示了增强数据表示的前景.
研究的目的:
- 调查SS-DRPL结合深度学习用于基于语音的PD分类的有效性.
- 评估和比较不同深度学习模型 (LSTM-RNN,DNN) 增强SS-DRPL.PL的性能.
- 使用传统的机器学习模型建立性能基线.
主要方法:
- 使用SS-DRPL从语音数据中提取功能.
- 实现并比较混合长短期记忆和循环神经网络 (LSTM-RNN) 和深度神经网络 (DNN) 架构.
- 集成的SS-DRPL与PD分类的深度学习模型.
- 包括用于比较分析的传统机器学习模型.
主要成果:
- 在所有实验设置中,SS-DRPL集成改善了模型性能.
- 与SS-DRPL相结合的LSTM-RNN架构实现了最高的F1得分,即0.94.
- 用SS-DRPL增强的深度学习模型在基于语音的PD检测中表现出卓越的准确性.
结论:
- SS-DRPL是一种有效的技术,用于增强基于语音的PD检测中的深度学习模型.
- 使用SS-DRPL的LSTM-RNN架构显示了准确和高效的PD分类的巨大潜力.
- 这种方法为改善帕金森病的早期诊断和干预策略提供了一个有希望的途径.
相关概念视频
Parkinson's Disease: Treatment
254
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Parkinson's Disease: Overview
523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523


